Show simple item record

dc.contributor.authorVuyst, Hugo De
dc.contributor.authorParisi, Maria Rita
dc.contributor.authorKarani, Andrew
dc.contributor.authorMandaliya, Kishor
dc.contributor.authorMuchiri, Lucy
dc.contributor.authorVaccarella, Salvatore
dc.contributor.authorTemmerman, M
dc.contributor.authorFranceschi, Silvia
dc.contributor.authorLillo, Flavia
dc.date.accessioned2013-06-21T12:07:01Z
dc.date.available2013-06-21T12:07:01Z
dc.date.issued2010
dc.identifier.citationCancer Causes & Control > Vol. 21, No. 12, December 2010en
dc.identifier.urihttp://www.jstor.org/stable/40983785?&Search=yes&searchText=karani&searchText=education&list=hide&searchUri=%2Faction%2FdoBasicSearch%3FQuery%3Dkarani%2BAND%2Beducation%26acc%3Don%26wc%3Don%26fc%3Doff&prevSearch=&item=3&ttl=118&returnArticleService=showFullText#authInfo
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/37518
dc.description.abstractObjectives A human papillomavirus (HPV) prevalence survey was done in Mombasa, Kenya, to improve the knowledge of HPV prevalence and genotype distribution in sub-Saharan African countries overall, and in women of different ages. Methods HPV prevalence was assessed using PCR in women older than 15 years attending family planning and mother-child care services. Results Among 496 women, HPV prevalence was high (42.3%; 95% CI: 37.9-46.8; world age-standardized). Moreover, 46% of HPV-positive women harbored multiple-type infections. The most common types were HPV58 (10.5% of women), HPV16 (7.7%), HPV53 (6.7%), HPV18 (4.6%), and HPV6 (4.4%), and the prevalence of any highrisk HPV type was 28.8%. HPV prevalence was elevated among all age-groups (range 36.4–45.7%). Independent associations with HPV positivity were found for being in a polygamous marriage (OR = 1.7) and lifetime number of sexual partners (OR for ≥3 vs. 1 = 1.5), although they were of only borderline statistical significance. Conclusions These findings differ from other world regions, showing a high HPV burden in all age-groups with a high proportion of multiple-type infections. Our data strengthen the urgency of HPV vaccination in Kenya but also highlight the elevated number of women who would have positive results in an HPV-based screening program in the countryen
dc.language.isoenen
dc.titleCancer Causes & Control > Vol. 21, No. 12, December 2010.en
dc.typeArticleen
local.publisherDepartment of Pathology, University of Nairobien


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record